Both in Pharmaceuticals
Processa Pharmaceuticals vs Skye Bioscience
Over the past year PCSA returned −77.6% and SKYE returned −90.0%; their daily moves had a correlation of -0.02.
PCSA −77.6% SKYE −90.0%Growth of $1, one year, split-adjusted
| Metric | PCSA | SKYE |
|---|---|---|
| Price | $1.94 | $1.14 |
| Market cap | $5.4M | $5.0M |
| Today | −0.26% | −6.56% |
| 1 month | +27.3% | −29.6% |
| 6 months | −29.6% | −83.3% |
| Year to date | −32.8% | −81.0% |
| 1 year | −79.1% | −90.5% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $196.3K | $9.9M |
| Dividend yield | — | — |
| Volatility (60d) | 87.6% | 616.5% |
| Short % of float | 2.2% | 0.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).